China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2012-01-31 01:30 Transgene Starts Two New China Ventures 2012-01-29 01:30 The Week in Review: Seven China Researchers Land $650,000 Howard Hughes Research Grants 2012-01-28 01:30 For Saladax Biomedical, China Could Be the Largest Market 2012-01-27 01:30 Seven Young China Scientists Given $650,000 Howard Hughes Awards 2012-01-26 01:30 Syneron Announces SFDA Approval for Five Aesthetic Machines 2012-01-25 01:30 SuperNova Developing Point of Care Diagnostics Technology 2012-01-24 01:30 EntreMed Raises $10 Million from China-Connected Investors 2012-01-22 01:30 The Week in Review: Xizang Haisco Pharma Completes $127 Million IPO 2012-01-21 01:30 China Scientists Given US Award for Cancer Breakthrough and more... 2012-01-20 01:30 Jiangsu Kanion Out-licenses 3 Molecules to NewGen Therapeutics and more... 2012-01-19 01:30 Quintiles Opens New Support Center for China Clinical Trials and more... 2012-01-18 01:30 Xizang Haisco Pharma Completes $127 Million IPO and more... 2012-01-17 01:30 Da An Gene and Life Technologies Form JV 2012-01-15 01:30 The Week in Review: China Featured at J.P. Morgan Confab and more... 2012-01-14 01:30 NovaBayÔö£éÔö¼?½ Chooses Pioneer to Market NeutroPhase in China and more... 2012-01-13 01:30 Amerigen Pharma Announces Two China-US Deals 2012-01-11 01:30 Aeras and CNBG Partner on TB Vaccine and more... 2012-01-10 01:30 Mindray Climbs on Improved 2011 Revenues 2012-01-08 01:30 The Week in Review: China Unveils Biotech Development Plan 2010-2020 2012-01-07 01:30 China Kanghui Granted FDA Approval for Two Joint Replacements 2012-01-06 01:30 China Announces Major Program for Biotechnology 2010-2020 and more... 2012-01-05 01:30 Darren Ji Steps Down as PharmaLegacy CEO and more... 2012-01-04 01:30 Vivo Ventures Closes $375 Million US-China Life Science Fund and more... 2012-01-01 01:30 The Week in Review: China Events at J.P. Morgan Healthcare Conference   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC